Join the Oncology Voice Network. Join for Free
Filler Words Fix the Problem You Didn't Know You Had
filler words communication skills professional presence audience engagement verbal fillers

Filler Words Fix the Problem You Didn't Know You Had


Share This Article


Summary

In this episode, Tom Caravela delves into the significance of eliminating filler words in professional as well as personal communication. He highlights the impact of these verbal fillers on perceived competence and interview performance, supported by revealing statistics. Tom explores the demographic differences in the use of filler words and their effects on audience engagement. He provides practical strategies for reducing filler words, emphasizing the importance of preparation, practice, and the power of slowing down and pausing. The episode concludes with insights on mindfulness and self-awareness in speech, encouraging listeners to refine their communication skills for enhanced professional presence.

Key Points

  • Eliminating filler words can significantly enhance your professional image, making you appear more confident and competent.
  • Preparation and practice are key to eliminating the need to fill gaps with habitual words.
  • Slowing down and embracing pauses in your speech can improve clarity and engagement, preventing the need for filler words.

Click for Source
filler words, communication skills, professional presence, audience engagement, verbal fillers

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Be Brave-A Networking Tale that Led to Friendship
Partner Avatar MSL Talk, Tom Caravela, Josh Yoder, Kirsten Borbe

Be Brave-A Networking Tale that Led to Friendship

Podcast
Top 5 MSL Frustrations and How to Overcome Them
Partner Avatar MSL Talk: Tom Caravela

Top 5 MSL Frustrations and How to Overcome Them

Podcast
MSL Career Options: The transition from Field Medical to Medical Director
Partner Avatar MSL Talk: Tom Caravela, Josh Corriveau

MSL Career Options: The transition from Field Medical to Medical Director

Article
EHA evaluation of the ESMO-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for hematological malignancies
OVN Avatar Barbara Kiesewetter , Nathan I Cherny, Nicolas Boissel, Francesco Cerisoli, Urania Dafni, Elisabeth G E de Vries, Paolo Ghia, Nicola Gökbuget, Verónica González-Calle, Brian Huntly, Ulrich Jäger, Nicola Jane Latino, Jean-Yves Douillard, Luca Malcovati, Ma

EHA evaluation of the ESMO-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for hematological malignancies

Article
Confounding factors in exposure–response analyses and mitigation strategies for monoclonal antibodies in oncology
OVN Avatar Sonoko Kawakatsu, René Bruno, Matts Kågedal, Chunze Li, Sandhya Girish, Amita Joshi, Benjamin Wu

Confounding factors in exposure–response analyses and mitigation strategies for monoclonal antibodies in oncology

Article
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
OVN Avatar Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li

Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?

Explore OVN